Observational studyCancer chemotherapy and pharmacology2020

Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients.

M Teresa Agulló-Ortuño et al.PubMed ↗Publisher ↗

No numbers read from the abstract.